Professional Documents
Culture Documents
ANANT R. KAPDI
Institute of Chemical Technology, Mumbai, India
DEBABRATA MAITI
Indian Institute of Technology, Mumbai, India
Elsevier
Radarweg 29, PO Box 211, 1000 AE Amsterdam, Netherlands
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
mechanical, including photocopying, recording, or any information storage and retrieval system, without
permission in writing from the publisher. Details on how to seek permission, further information about the
Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance
Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher
(other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience broaden
our understanding, changes in research methods, professional practices, or medical treatment may become
necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and
using any information, methods, compounds, or experiments described herein. In using such information or
methods they should be mindful of their own safety and the safety of others, including parties for whom they
have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any
liability for any injury and/or damage to persons or property as a matter of products liability, negligence or
otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the
material herein.
ISBN: 978-0-12-805254-9
Bhalchandra M. Bhanage
Institute of Chemical Technology, Mumbai, Maharashtra, India
Aniruddha Dey
Indian Institute of Technology Bombay, Mumbai, Maharashtra, India
Uttam Dhawa
Indian Institute of Technology Bombay, Mumbai, Maharashtra, India
Ian J.S. Fairlamb
University of York, York, United Kingdom
Prashant Gautam
Institute of Chemical Technology, Mumbai, Maharashtra, India
Vijay Gayakhe
Institute of Chemical Technology, Mumbai, Maharashtra, India
Aniket Gholap
Institute of Chemical Technology, Mumbai, Maharashtra, India
Ye-Qiang Han
Zhejiang University, Hangzhou, China
Fang Hu
Zhejiang University, Hangzhou, China
Lin-Yu Jiao
Northwest University, Xi’an, Shaanxi, PR China
Anant R. Kapdi
Institute of Chemical Technology, Mumbai, Maharashtra, India
Fuk-Yee Kwong
The Hong Kong Polytechnic University, Kowloon, Hong Kong; The Chinese
University of Hong Kong, Shatin, New Territories, Hong Kong
Gabriele Laudadio
Eindhoven University of Technology, Eindhoven, The Netherlands
Gang Li
Fujian Institute of Research on the Structure of Matter, Chinese Academy of
Sciences, Fuzhou, Fujian, China
Bin Liu
Zhejiang University, Hangzhou, China
Debabrata Maiti
Indian Institute of Technology Bombay, Mumbai, Maharashtra, India
ix
x List of Contributors
Timothy Noël
Eindhoven University of Technology, Eindhoven, The Netherlands
Martin Oestreich
Technical University of Berlin, Berlin, Germany
Benudhar Punji
CSIR-National Chemical Laboratory (CSIR-NCL), Pune, Maharashtra, India
Bing-Feng Shi
Zhejiang University, Hangzhou, China
Vineeta Soni
CSIR-National Chemical Laboratory (CSIR-NCL), Pune, Maharashtra, India
Neetipalli Thrimurtulu
Indian Institute of Technology Bombay, Mumbai, Maharashtra, India
Chandra M.R. Volla
Indian Institute of Technology Bombay, Mumbai, Maharashtra, India
Shun-Man Wong
The Hong Kong Polytechnic University, Kowloon, Hong Kong
FOREWORD
xi
xii Foreword
Introduction
Aniruddha
1
Dey1, Anant R. Kapdi2 and Debabrata Maiti1
Indian Institute of Technology Bombay, Mumbai, Maharashtra, India
2
Institute of Chemical Technology, Mumbai, Maharashtra, India
Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization © 2017 Elsevier Inc.
DOI: http://dx.doi.org/10.1016/B978-0-12-805254-9.00001-3 All rights reserved. 1
2 Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization
metals used for catalytic conversions stands legion, and a vivid discourse
encompassing all of them is beyond a corporeal attempt. Undoubtedly,
the countable occasions in which palladium was used to perform such
historical transformations are innumerable. This could be attributed to
its greater catalytic efficiency, ease of procurement, and a multitude of
advantages, coupled with the cost-effectiveness. Subsequent chapters
in this book therefore revolve around chemical strategies which discern
palladium as a catalyst, and thus rightfully recognize it as the protagonist
in the book’s context (Fig. 1.1).
The opening chapter introduces readers to the fascinating diorama of
ligand supported functionalization of CaH bonds in aromatic cores.
Owing to the synthetic significance of metal-mediated CaH activation
strategies, the benefit of using ligands are well-precedented in the literature
existence and shall remain the same for eternity. Attempts to bring mod-
ernization into chemistry led to the development of CaH activation-
based protocols which have significantly reshaped scientific temperament
and created a novel dimension for rethinking synthetic transformations.
This book, besides summarizing the notion of scientific progress made in
the field of palladium-catalyzed CaH functionalization in recent times,
aims to inculcate cognizance among the scientific fraternity about the
same, and wishes to encourage chemists of both the present and future
generations to contribute their ideas towards the welfare of the scientific
community, as well as for all and sundry.
CHAPTER 2
Contents
2.1 Introduction 9
2.2 Ortho-Palladated CaH Bond Functionalization via Directing Group Effect 11
2.2.1 Effect of Coordination Capacity on Functionalization 11
2.3 Conclusion 45
References 46
2.1 INTRODUCTION
Organic synthesis in recent decades has undergone a tremendous change
with the advent of catalytic processes providing an efficient alternative to
non-catalyzed reactions. The unparalleled success obtained by these cata-
lytic processes was based on the rapid development of newer and more
efficient catalytic systems functioning under milder reaction conditions.
Selective functionalization of a variety of unactivated bonds having appli-
cations across a wide spectrum of fields has contributed further to the
popularity of these processes. The prerequisite for achieving the required
success involves the pre-functionalization of the substrate leading to fur-
ther activation of other bonds. Although the installation of CaO, CaX,
CaN, and CaC bonds could be achieved via these processes, cost escala-
tion for the multi-step reactions renders the overall process commercially
less attractive. Circumventing this problem would involve the possibility
of employing an unfunctionalized substrate that could be directly functio-
nalized without the requirement for a prefunctionalization step.
Direct functionalization via the activation of unreactive CaH bonds
could provide researchers with the required sustainable solution that could
Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization © 2017 Elsevier Inc.
DOI: http://dx.doi.org/10.1016/B978-0-12-805254-9.00002-5 All rights reserved. 9
10 Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization
of this chapter, and readers are advised to refer to some of the recent liter-
ature on this topic,4 as well as the further chapters of this book where
these topics are discussed in depth by Li and Maiti.
O Me NH
O C—H activation R
Me NH
Me NH
[Pd]
HO O
C—H activation
R
Pd precursor
XO O
[Pd]
XO O
Figure 2.2 Energy representation for strong and weakly coordinating ligands in CaH
bond activation processes.
N N
Pd(OAc) 2 (5.0 mol%)
(A) + [Ph 2 I]BF4 Ph
AcOH/Ac 2 O,
100ºC, 8 h
Me
Me
Pd(OAc) 2 (5.0 mol%)
Oxone (2.0 equiv.) N
(B) N
N i PrOH, 25ºC, 17 h
Me
Scheme 2.1 (A) Functionalization using diphenyliodonium salt; (B) oxidative homo-
coupling of phenylpyridines using oxone as the oxidant.
14 Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization
I
Pd(OAc) 2 (5.0 mol%) N R2
AgOAc (3.0 equiv.)
(A)
AcOH, 100°C
R2 longer reaction times R1
N
+
Si(OMe) 3
Pd(OAc) 2, N R3
Benzoquinone
R1 (B)
AgF, 1,4-dioxane
R3 100°C R1
Scheme 2.2 (A) Aryl iodides as the arylating agents; (B) aryltrimethoxysilanes as cou-
pling partners.
Scheme 2.3 Boron reagents for arylation: (A) potassium aryltrifluoroborates; (B) aryl-
boronic acids.
Scheme 2.4 Pyridine as directing group for olefination leading to 6,5-N-fused bicyclic
cores.
16 Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization
N N N
R Pd(OAc) 2 (10 mol%)
+ O
O Me Me Me
R 130°C, 12 h, N2
R = H or Ph
2-Phenylpyridine:peroxide = 1 : 1 50% 0%
N
R
relevance. The first example of CaH cyanation using CuCN as the cya-
nide source was reported in 2009 by Cheng and co-workers19
(Scheme 2.8A). The cyanation protocol thus developed was applied to
the synthesis of a key intermediate of an alkaloid, Menispermum dauri-
cum DC, which is known to exhibit promising analgesic and antipyretic
properties. An important advanceinvolving a palladium(II)/magne-
siumalanthanum mixed oxide as a heterogeneous catalyst for palladium-
catalyzed CaH cyanation of phenylpyridines was put forth by Kantam
and co-workers in 2015 (Scheme 2.8B).17 In situ generation of CN2 was
made possible from the combination of NH4HCO3 and DMSO, rather
than the commonly applicable inorganic cyanide sources. Besides achiev-
ing excellent regioselectivity for cyanation, the catalytic solution was also
found to be recyclable for up to three cycles. The active nature of the
heterogeneous catalyst allowed a tandem Suzuki coupling/CaH cyana-
tion reaction of 2-halopyridines.
18 Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization
O
N
H Pd(OAc) 2 (10 mol%) O
(A)
Xylene, air (1 atm),
R2 120°C, 24 h
R 2 = 4-Me, 4-CN, R1 R2
3-NO2, 4-MeO
24 examples, 40%–90%
OAc
N L N L
PhI(OAc) 2
PdII PdIV
Oxidation L
L
OAc
R R [A]
OAc X
N N
OAc OAc (ref 26)
(78%, ref=25) X= F 59% X = CF3 81%
X = Br 83% X = OMe 78%
Scheme 2.10 Selective acetoxylation of phenylpyridines.
Pd(OAc) 2 (1–2mol%)
Halogenating reagent
R N R N
X
Halogenating reagents = NXS (X = Cl or Br) Ref. [25]
= CuX2 (X = Cl or Br) Ref. [31]
= PhICl2 Ref. [28c]
= HX (X = Cl or Br) Ref. [32]
R1 N R2
R1 N R2 R1 N R2
I I
4 examples (97–97%) 4 examples (59–92%)
N BF4 N
Pd(OAc)2 (10 mol%)
+ N F F
0.5 mL MeCNin CF3C 6H 5
microwave, 150°C, 1.5 h
R 5 examples, 33–75% R
OR 2
Pd(OAc) 2
/TsOH β -hydride
elimination
H H H
N Me N Me N Me
-TsOH
O O
O
R1 1 OR 2 R1
H Pd R Pd
S OTs OR 2
TsO TsO 2 Pd
O
OTs O
Palladacycle intermediate
R2
Me O
H I Pd(OAc)2(0.2–5.0 mol%)
H
N Me AgOAc (1.0 equiv.) NH N
COMe
(A)
O 2 TFA, 90–130°C
1 1 1
R R R R
2
R R2
O
H I Pd(OAc)2(5.0 mol%) MeO
Br N AgOAc (1.3–2.3 equiv.) Br NH
OMe
(B)
O TFA, 110–120°C
R
R
TFAA
(2.0-3.0 equiv.)
110°C, 0.5–3.0 h
Br N
OMe
R3
Me O
O
H Pd(OAc) 2 (7.5 mol%)
N Me O NH
O TfOH (2.0 equiv.)
(A)
O O 3 A MS, MeCN, 80°C, 32 h
R1 R1
18 examples, 33%–81%
R2 O
H
N R2 O NH
(A) Pd precursor
O R3 H R3
TBHP as the oxidant
R1 R1
O
R2 O
H 2 OH
N R NH
(B) Pd precursor
R3 H
O TBHP as the oxidant R3
R1 R1
O
Scheme 2.19 Aldehydes and alcohols as acylating agents for anilide-directed acyla-
tion strategy. A) Aldehydes as acylating reagents B) Alcohols as acylating reagents
O R2 O
H
NH 2 Ac O N R2 NH 2
2 R3 H NH
H2O, SDS O Pd(OAc) 2, TFA, HCl, 125°C R3
R1 r.t. 0.5 h R1 TBHP, r.t. 24 h R3 R1
R1 3h O
O
O O
O O O
Me NH O Me NH O Me NH O
Br Cl Br
80% 91% 60%
Scheme 2.21 Acylation strategy using α-oxocarboxylic acid.
O H O
H H
HN Me C Me NH O
Pd(OAc) 2 /TBHP
R2
2
R1 R R1
O O
HN R2 R2 NH
(B) Pd(OAc) 2 (5.0 mol%) Cl
CuCl 2 (2.0 Equiv.)
R1 Solvent-free, 120°C, 24 h R1
10 mmol scale, 13 mm diameter tube, 66%
10 mmol scale, 13 mm diameter tube, Cu(OAc) 2 (2.0 equiv.), 89%
10 mmol scale, 55 mm diameter beaker, 84%
100 mmol scale, 70 mm diameter beaker, 89%
O O
HN R2 R2 NH
Pd(OAc) 2 (5.0 mol%)
(C) NXS (2.0 equiv.) X
PTSA (0.5 equiv.)
PhMe, r.t., 1–4 h R1
R1
X = Br or Cl
H
N R
O
Pd
L L
[B]
the active species involved in the catalytic cycle for the functionalization.
Bedford and co-workers followed this up with a solvent-free palladium-cata-
lyzed CaH bond activation 2 halogenation protocol for scale-up possibilities
(Scheme 2.23B).58 The reaction conditions were the same as those devel-
oped by Shi, although the solvent was completely removed as part of the
scale-up procedure, with the catalytic reaction performed with and without
Cu(OAc)2 still resulting in good-to-excellent yields.
Based on the initial assumptions for the presence of palladacyclic inter-
mediates as a part of the functionalization process, Bedford and co-workers
developed a mild and selective ortho-halogenation protocol, with
30 Strategies for Palladium-Catalyzed Non-Directed and Directed C H Bond Functionalization
O O
O O
R2 R2
HN N N NH O
H Pd(OAc)2/pTsOH H
(A) OBu
OBu
Benzoquinone/AcOH
O
R1 r.t. –60°C R1
O OTf O
CF3 R2
R2 Pd(OAc)2(7.5 mol%)
HN N I N NH
TFA (2.0–3.0 equiv.) H
(B) R3 Me Me
CF3
CH2Cl2, 25°C, 3 h
R1 34 examples, 53%–95% R1
Me
Scheme 2.25 Urea as a directing group for olefination and trifluoroalkylation.
A) Olefination using acrylates B) Trifluoroalkylation using iodonium salt
H H
Pd(OAc)2 (10 mol%) N O
R2
DMF (2.0 equiv.) R3
(A) R2 = (4-CF 3)C6F5
NFSI (1.5 equiv.)
H R3
O N 70°C, 48 h
R2 R1
R1
OMe
I
Pd(OAc) 2 (5.0 mol%) O N
H
Ag2O (2.0 equiv.) R3
(A)
H AcOH, 120°C, 24–72 h
R3
O N R1
OMe
H
OMe
H
Pd(OAc) 2 (5.0 mol%) O N
R1 H K2S2O 8 (2.0 equiv.) R3
(B)
R3 TFA (20 equiv.), 25°C, 16 h
R1
Scheme 2.28 Phenanthridinone synthesis via one-pot multi CaH bond activations.
A) Using Aryl iodides B) Using arenes
F F
I PdCl2 (10 mol%)
F CF3 2,5-Lutidine (20 mol%) F CF3
Ag 2CO3 (3.0 equiv.)
HN F tAmylOH, 140°C, 24 h N F
Me F F
O O
Arylation
Carbonylation
MeO MeO
Ha Carboxylation
O O X
O O
Hc S Hc S
NHC 6 F5 NHC 6 F5
Hb Halogenation Hb
N N
N N
F3C Methylation F3C Celecoxib